1. P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECITABINE IN AML PATIENTS. (23rd June 2022) Authors: Geissler, K.; Koristek, Z.; Bernal del Castillo, T.; Novák, J.; Rodriguez Macias, G.; Metzelder, S. K.; Illes, A.; Nagy, A.; Mayer, J.; Arnan, M.; Keating, M.-M.; Krauter, J.; Lunghi, M.; Stefano Fracchiolla, N.; Platzbecker, U.; Santini, V.; Sano, Y.; Oganesian, A.; Keer, H.; Lübbert, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY. (23rd June 2022) Authors: Garcia-Manero, G.; Bart, S.; McCloskey, J. K.; Fenaux, P.; Selleslag, D.; Reda, G.; Valcárcel, D.; Santini, V.; Mayer, J.; Xicoy, B.; Yamaguchi, H.; Lübbert, M.; Miyazaki, Y.; Keer, H.; Hao, Y.; Azab, M.; Döhner, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS08-Treatment/AS08a-Current treatment options - Hypomethylating agents: PROLONGED SURVIVAL OBSERVED IN 133 MDS PATIENTS TREATED WITH ORAL DECITABINE/CEDAZURIDINE. (September 2021) Authors: Savona, M.; Mccloskey, J.; Griffiths, E.; Yee, K.; Al-Kali, A.; Zeidan, A.M.; Deeg, H.J.; Patel, P.; Sabloff, M.; Keating, M.-M.; Dao, K.-H.; Zhu, N.; Gabrail, N.; Fazal, S.; Maly, J.; Odenike, O.; Kantarjian, H.; Dezern, A.; O'Connell, C.; Roboz, G. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: PHASE 1 STUDY EVALUATING LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS. (May 2023) Authors: Garcia-Manero, G.; Bachiashvili, K.; Amin, H.; Traer, E.; Pollyea, D.; Sallman, D.; Al-Kali, A.; Cripe, L.; Berdeja, J.; Griffiths, E.; Mohan, S.; Vachhani, P.; Sano, Y.; Oganesian, A.; Keer, H.; Yacoub, A. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES. (May 2023) Authors: Savona, M.; Mccloskey, J.; Griffiths, E.; Yee, K.; Zeidan, A.; Al-Kali, A.; Deeg, H.J.; Patel, P.; Sabloff, M.; Keating, M.-M.; Zhu, N.; Gabrail, N.; Fazal, S.; Maly, J.; Odenike, O.; Kantarjian, H.; Dezern, A.; O'Connell, C.; Roboz, G.; Busque, L. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PHASE 2 STUDY OF ORAL DECITABINE AND CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS). (May 2023) Authors: Zeidan, A.; Mosher, K.; Souza, S.; Mirakhur, B.; Taylor, J.; Keer, H. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS. (May 2023) Authors: Garcia-Manero, G.; Bachiashvili, K.; Griffiths, E.; Traer, E.; Saini, L.; Amin, H.; Zeidan, A.; Mohan, S.; Lübbert, M.; Maness, L.; Foran, J.; Selleslag, D.; Xicoy, B.; Pollyea, D.; Sallman, D.; Al-Kali, A.; Berdeja, J.; Al-Ali, H.; Zhu, N.; Lopez, P. Font Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗